CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Rubin Steven D Director | Grant or award | +19,117 | 34,117 | ||
| 2026-08-07 | Rubin Steven D Director | Grant or award · Stock Option (right to buy) | +33,368 | 33,368 | ||
| 2026-08-07 | Rubin Steven D Director | Grant or award · Stock Option (right to buy) | +43,405 | 43,405 | ||
| 2026-08-07 | Malca Yonatan Director | Grant or award | +22,815 | 100,231 | ||
| 2026-08-07 | Taitel Haya Director | Grant or award | +20,790 | 119,269 | ||
| 2026-08-07 | Ellis Sean Director | Grant or award | +20,034 | 208,132 | ||
| 2026-08-07 | Ellis Sean Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-08-07 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2026-08-07 | Galitzer Hillel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-08-07 | Burshtein Gregory Chief of R&D | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2026-08-07 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2026-08-07 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-08-07 | Germano Geno J Director | Grant or award | +25,014 | 65,014 | ||
| 2026-08-07 | Germano Geno J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-08-07 | Germano Geno J Director | Grant or award · Stock Option (right to buy) | +43,014 | 43,014 | ||
| 2026-07-14 | Toledano Miranda Jayne Chief Executive Officer | Grant or award | +347,567 | 774,142 | ||
| 2026-07-14 | Toledano Miranda Jayne Chief Executive Officer | Grant or award | +72,993 | 847,135 | ||
| 2026-05-07 | Galitzer Hillel Chief Operating Officer | Grant or award | +72,993 | 163,566 | ||
| 2026-05-07 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award | +58,394 | 171,441 | ||
| 2026-05-07 | Burshtein Gregory Chief of R&D | Grant or award | +87,591 | 189,033 |
Page 1 of 8 · 147 trades